CD44 and neoplasm: In the context of glioma progression, CHI3L1 is released into the tumor microenvironment and interacts with CD44 expressed on tumor-associated macrophages, thereby activating the downstream PI3K/Akt signaling pathway and contributing to M2 macrophage polarization [71].